Combination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza Virus

類似資料

• Evaluation of Serological Diagnostic Methods for the 2009 Pandemic Influenza A (H1N1) Virus
  著者:: Papenburg, Jesse, 等
  出版事項: (2011)
• Activity of the Oral Neuraminidase Inhibitor A-322278 against the Oseltamivir-Resistant H274Y (A/H1N1) Influenza Virus Mutant in Mice
  著者:: Baz, Mariana, 等
  出版事項: (2009)
• Evolution of Oseltamivir Resistance Mutations in Influenza A(H1N1) and A(H3N2) Viruses during Selection in Experimentally Infected Mice
  著者:: Pizzorno, Andrés, 等
  出版事項: (2014)
• Impact of Potential Permissive Neuraminidase Mutations on Viral Fitness of the H275Y Oseltamivir-Resistant Influenza A(H1N1)pdm09 Virus In Vitro, in Mice and in Ferrets
  著者:: Abed, Yacine, 等
  出版事項: (2014)
• Synergistic combinations of favipiravir and oseltamivir against wild-type pandemic and oseltamivir-resistant influenza A virus infections in mice
  著者:: Smee, Donald F, 等
  出版事項: (2013)